Project description:The Antibiotic Resistant Sepsis Pathogens Framework Initiative aims to develop a framework dataset of 5 sepsis pathogens (5 strains each) using an integrated application of genomic, transcriptomic, metabolomic and proteomic technologies. The pathogens included in this initiative are: Escherichia coli, Klebsiella pneumoniae complex, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae. This submission pertains to strain B36.
Project description:The Antibiotic Resistant Sepsis Pathogens Framework Initiative aims to develop a framework dataset of 5 sepsis pathogens (5 strains each) using an integrated application of genomic, transcriptomic, metabolomic and proteomic technologies. The pathogens included in this initiative are: Escherichia coli, Klebsiella pneumoniae complex, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae. This submission pertains to strains MS14386.
Project description:The Antibiotic Resistant Sepsis Pathogens Framework Initiative aims to develop a framework dataset of 5 sepsis pathogens (5 strains each) using an integrated application of genomic, transcriptomic, metabolomic and proteomic technologies. The pathogens included in this initiative are: Escherichia coli, Klebsiella pneumoniae complex, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae. This submission pertains to strain MS14387.
Project description:The Antibiotic Resistant Sepsis Pathogens Framework Initiative aims to develop a framework dataset of 5 sepsis pathogens (5 strains each) using an integrated application of genomic, transcriptomic, metabolomic and proteomic technologies. The pathogens included in this initiative are: Escherichia coli, Klebsiella pneumoniae complex, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae. This submission pertains to strain MS14384.
Project description:The Antibiotic Resistant Sepsis Pathogens Framework Initiative aims to develop a framework dataset of 5 sepsis pathogens (5 strains each) using an integrated application of genomic, transcriptomic, metabolomic and proteomic technologies. The pathogens included in this initiative are: Escherichia coli, Klebsiella pneumoniae complex, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae. This submission pertains to Escherichia coli strains B36, MS14384, MS14385, MS14386 and MS14387.
Project description:The Antibiotic Resistant Sepsis Pathogens Framework Initiative aims to develop a framework dataset of 5 sepsis pathogens (Escherichia coli, Klebsiella pneumoniae complex, Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes, 5 strains each) using an integrated application of genomic, transcriptomic, metabolomic and proteomic technologies. This submission contains the results from five Escherichia coli strains (B36, MS14384, MS14385, MS14386, MS14387) grown in either RPMI or pooled human sera. Six replicates of each condition were subjected to shotgun proteomics and label-free MS1-based quantitation.
Project description:The purpose of this study is to determine whether the presence of pathogenic Escherichia coli in colon is associated with psychiatric disorders.
Project description:Despite the characterization of many aetiologic genetic changes. The specific causative factors in the development of sporadic colorectal cancer remain unclear. This study was performed to detect the possible role of Enteropathogenic Escherichia coli (EPEC) in developing colorectal carcinoma.
Project description:<p>The Antibiotic Resistant Sepsis Pathogens Framework Initiative aims to develop a framework dataset of 5 sepsis pathogens (5 strains each) using an integrated application of genomic, transcriptomic, metabolomic and proteomic technologies. The pathogens included in this initiative are: <em>Escherichia coli</em>, <em>Klebsiella pneumoniae</em> complex, <em>Staphylococcus aureus</em>, <em>Streptococcus pyogenes</em>, and <em>Streptococcus pneumoniae</em>. This submission is specifically for <em>Escherichia coli</em>.</p><p><br></p><p><strong>GC-MS and LC-MS <em>Escherichia coli </em>assays</strong> are reported in the current study <strong>MTBLS2015</strong></p><p><strong>GC-MS and LC-MS <em>Staphylococcus aureus</em> assays</strong> are reported in <a href='https://www.ebi.ac.uk/metabolights/MTBLS1898' rel='noopener noreferrer' target='_blank'><strong>MTBLS1898</strong></a></p><p><strong>GC-MS and LC-MS <em>Klebsiella pneumoniae</em> assays</strong> are reported in <a href='https://www.ebi.ac.uk/metabolights/MTBLS2322' rel='noopener noreferrer' target='_blank'><strong>MTBLS2322</strong></a></p><p><strong>GC-MS and LC-MS <em>Streptococcus pneumoniae</em> assays</strong> are reported in <a href='https://www.ebi.ac.uk/metabolights/MTBLS2323' rel='noopener noreferrer' target='_blank'><strong>MTBLS2323</strong></a></p><p><strong>GC-MS and LC-MS <em>Streptococcus pyogenes</em> assays</strong> are reported in <a href='https://www.ebi.ac.uk/metabolights/MTBLS2324' rel='noopener noreferrer' target='_blank'><strong>MTBLS2324</strong></a></p>